(19)
(11) EP 4 507 679 A1

(12)

(43) Date of publication:
19.02.2025 Bulletin 2025/08

(21) Application number: 23719009.5

(22) Date of filing: 07.04.2023
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/2054
(86) International application number:
PCT/EP2023/059303
(87) International publication number:
WO 2023/198640 (19.10.2023 Gazette 2023/42)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 11.04.2022 EP 22167555
11.04.2022 US 202217717922

(71) Applicant: Chiesi Farmaceutici S.p.A.
43122 Parma (IT)

(72) Inventors:
  • PERTILE, Marisa
    43122 Parma (IT)
  • GAZZANIGA, Andrea
    20122 Milano (IT)
  • CEREA, Matteo
    20122 Milano (IT)
  • CIRILLI, Micol
    20122 Milano (IT)

(74) Representative: Chiesi Farmaceutici S.p.A. 
Via Palermo, 26/A
43122 Parma
43122 Parma (IT)

   


(54) MODIFIED RELEASE PHARMACEUTICAL FORMULATIONS COMPRISING DEFERIPRONE